Yorktown Management & Research Company’s CVS Health CVS Stock Holding History

Yorktown Management & Research Company’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,558	Closed	-$237K	–	204
2022 Q2	$237K	Hold	2,558	–	–	0.31%	146
2022 Q1	$259K	Sell	2,558 -412	-14%	-$43.3K	0.22%	180
2021 Q4	$306K	Sell	2,970 -320	-10%	-$29.6K	0.21%	181
2021 Q3	$279K	Hold	3,290	–	–	0.21%	193
2021 Q2	$275K	Hold	3,290	–	–	0.22%	190
2021 Q1	$248K	Sell	3,290 -3,750	-53%	-$273K	0.21%	193
2020 Q4	$481K	Buy	7,040 +840	+14%	+$54.6K	0.43%	80
2020 Q3	$362K	Buy	6,200 +1,100	+22%	+$68.4K	0.34%	136
2020 Q2	$331K	Sell	5,100 -7,700	-60%	-$485K	0.3%	123
2020 Q1	$759K	Sell	12,800 -6,400	-33%	-$427K	0.77%	21
2019 Q4	$1.43M	Hold	19,200	–	–	0.77%	15
2019 Q3	$1.21M	Sell	19,200 -18,400	-49%	-$1.09M	0.65%	16
2019 Q2	$2.05M	Buy	37,600 +14,900	+66%	+$802K	0.77%	24
2019 Q1	$1.22M	Buy	22,700 +2,700	+14%	+$167K	0.4%	60
2018 Q4	$1.31M	Hold	20,000	–	–	0.43%	60
2018 Q3	$1.57M	Hold	20,000	–	–	0.46%	55
2018 Q2	$1.29M	Buy	20,000 +10,000	+100%	+$659K	0.37%	68
2018 Q1	$622K	Hold	10,000	–	–	0.18%	124
2017 Q4	$725K	Buy	+10,000	New	+$727K	0.21%	112

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Yorktown Management & Research Company's CVS Position: Q3 2022 in Review

Yorktown Management & Research Company sold out of CVS Health (CVS) in Q3 2022, closing a stake of 2,558 shares — an estimated $237K sold.

Yorktown Management & Research Company first reported a position in CVS in Q4 2017 and held it in 19 quarters. The position peaked at $2.05M in Q2 2019. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

Yorktown Management & Research Company reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
Yorktown Management & Research Company sold 2,558 CVS Health shares in Q3 2022, an estimated $237K.
Yorktown Management & Research Company first reported a position in CVS Health in Q4 2017 and held it in 19 quarters.
Yorktown Management & Research Company's CVS Health position peaked at $2.05M in Q2 2019.
2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Yorktown Management & Research Company's 13F filing for Q3 2022, filed 4 Nov 2022.